AZD4619 is an orally active, selective peroxisome proliferator-activated receptor alpha (PPARalpha) agonist. AZD4619 increases alanine aminotransferase 1 (ALT1) protein expression in a dose-dependent manner in human, but not in rat primary hepatocytes. AZD4619 is a lipid-lowering drug[1][2].
Molecular Weight:
516.63
CAS Number:
[549494-39-5]
Formula:
C26H28O7S2
Target:
PPAR
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
